CURRENT ISSUE Current Issue Cover
VOL 8 • NO 7 NOV/DEC 2017
IN THIS ISSUE

Innovations in Cancer Therapies and Rising Costs

Pamela Hallquist Viale, RN, MS, CNS, ANP



Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies

Ali McBride,(1) PharmD, MS, BCPS, BCOP, Steven Trifilio,(2) RPh, Nadine Baxter,(3) MNSc, APN-BC, AOCNP®, Tara K. Gregory,(4) MD, and Scott C. Howard,(5) MD, MS

 
Section Seperator

TODAY'S NEWS

ACKC Secures $10 Million for Kidney Canc...

Action to Cure Kidney Cancer (ACKC) was instrument...

Long-Term Risk of Breast Cancer Recurren...

In a meta-analysis reported in The New England Jou...

Constructing a Risk Stratification Model...

In a study reported in the Journal of Clinical Onc...

Seattle Children’s Opens Trial for Child...

Seattle Children’s has opened the first chim...

ESMO Asia 2017: FLAURA Trial: Osimertini...

Osimertinib improves progression-free survival com...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Lenalidomide-Associated Cytopenias in MDS

A male patient aged 67 years with a 2-year history of refractory anemia and myelodysplastic syndromes..

Anaplastic Lymphoma Kinase Inhibitors for NSCLC

Lung cancer is the second most commonly diagnosed cancer in the U.S., with an estimated 222,500 new cases in 2017...

Li-Fraumeni Syndrome

Li-Fraumeni syndrome is a rare inherited autosomal-dominant disorder that is manifested by a wide range of malignancies that appear at an unusually early age...

Immunotherapy Through the Years

Immunotherapy’s use in oncology has emerged in recent years as an important treatment option in many different disease sites...

Lenvatinib for Thyroid Cancer and Advanced RCC

Differentiated thyroid cancer (DTC) is a malignancy that is occurring with greater frequency...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

ESMO Asia 2017: AXEPT Trial: New Second-...

A randomized trial in 650 patients has confirmed t...

Patient-Reported Outcomes With Immunothe...

Pembrolizumab treatment was associated with improv...

Antidepressant for Aromatase Inhibitor&#...

The phase III SWOG S1202 trial has shown a benefit...

Predictors of Cervical Precancer Treatme...

In a meta-analysis reported in <em>The Lance...

ESMO Asia 2017: Analysis of Mutations in...

In a study presented at the European Society for M...

More Highlights More Highlights
Section Seperator

LATEST TWEETS







More Tweets More Tweets
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here